Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events
Gill Holdsworth, James R Staley, Peter Hall, Ian D. van Koeverden, Ciara Vangjeli, Remi Okoye, Rogely Waite Boyce, James R. Turk, Martin Armstrong, Alison Wolfreys, Gerard Pasterkamp
The paper investigates whether reduced sclerostin expression is linked to cardiovascular events by analyzing genetic variants and immunohistochemical data from atherosclerotic plaques.
Journal of Bone and Mineral Research · Dec 1, 2020Peer-reviewedGenetic & Genomic Medicine